Many studies have demonstrated that both fasting and the postprandial enhancement of ATBF are impaired in obesity and insulin-resistant conditions [6–8], thereby contributing to the metabolic perturbations in insulin-resistant individuals with obesity [1,3,7–10]. The gene discussed is INS; the disease is Obesity.